Back to search
Partial Drug-resistant Epilepsy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Partial Drug-resistant Epilepsy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Partial Drug-resistant Epilepsy trials you may qualify forThe purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
Brain somatic mutations are increasingly recognized as a major cause of focal epilepsies. These include mTOR pathway mutations underlying cortical malformations…
This will be a prospective, pilot, open-label, two-arm, parallel-group, randomized study to evaluate the efficacy and safety of low-intensity focused ultrasound…
Background: \- Drug resistant epilepsy is the term used to describe epilepsy that cannot be controlled by medication. Many people whose seizures do not respond…
The purpose of this study is to evaluate the safety and feasibility of using seizure forecasts based on subscalp EEG.
Epilepsy is a common disease affecting 0.5 to 1% of the general population. Epilepsies refractory to drug treatment lead to increased morbidity, mortality and h…
The main objective of this study is to evaluate the feasibility of recording fast-ripples, a potential new biomarker of epilepsy, using the new micro-macroelect…
A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy